1,488 followers
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fractio… https://t.co/s2dLMC3m9L
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fractio… https://t.co/s2dLMC3m9L
New Research: Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region: Background: EMPEROR-Reduced trial… https://t.co/PDRv7sQ8